Cross-correlation of serum Chromogranin A, %-F-PSA and bone scans in prostate cancer diagnosis

Anticancer Research

Volumn 21, Issue 2 B, 2001, Pages 1363-1366

  Zaky Ahel, M ^a   Kovacic, K ^a   Tarle, M ^a  

^a SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

Author keywords

F PSA; Diagnosis; Neuroendocrine structures; Prostate cancer; Serum CgA

Indexed keywords

CHROMOGRANIN A; HORMONE; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; BONE METASTASIS; BONE SCINTISCANNING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; PROTEIN BLOOD LEVEL; SEROLOGY;

BONE AND BONES; CHROMOGRANIN A; CHROMOGRANINS; FALSE NEGATIVE REACTIONS; HUMANS; MALE; NEOPLASM STAGING; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS;

EID: 0035000655     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Problem of prostate cancer
2. Gene therapy in prostate cancer and predictors of outcome
3. Serum prostate specific antigen complexed to alpha-1-antichymotrypsin as an indicator of prostate cancer
4. Free and total serum PSA values in patients with prostatic intraepithelial neoplasia (PIN), prostate cancer and BPH. Is PSA a potential probe for dormant and manifest cancer?
5. Pathology of carcinoma of the prostate
6. Neuroendocrine differentiation of carcinoma of the prostate
7. Xenografted small cell undifferentiated cancer of the prostate: Possible common origin with prostatic adenocarcinoma
8. Immunohistochemical staining and serotest markers during development of a sarcomatoid and small cell prostate tumor
9. Elevated plasma chromogranin-A concentrations in prostatic carcinoma
10. Neuroendocrine differentiation in prostatic carcinoma
11. Neuroendocrine differentiation in prostatic carcinoma: An update
12. Serum Chromogranin A in monitoring metastatic prostate cancer patients
13. Circulating neuroendocrine markers in patients with prostate carcinoma
14. Investigation on serum neurone specific enolase in prostate cancer diagnosis and monitoring: Comparative study of a multiple tumor marker assay
15. Serum Chromogranin A: Early detection of hormonal resistance in prostate cancer patients
16. Serum chromogranin A (ChrA) level vs. false negative %F-PSA data in prostate cancer diagnosis
17. Unusual prostatic carcinomas
18. Small cell anaplastic carcinoma of the prostate: A clinical, pathological and immunohistochemical study of 27 patients
19. A more objective staging of advanced prostate cancer. Routine recognition of malignant endocrine structures: The assessment of serum TPS, PSA and NSE values
20. Regressive changes and neuroendocrine differentiation prostate cancer after neoadjuvant hormonal therapy
21. Neuroendocrine cells in the prostatic carcinoma after neoadjuvant hormonal therapy